Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Nov, 20 2025
Jun, 4 2026
Feb, 4 2026
Nov, 19 2025
Jun, 18 2026